An LSU-led research team is developing a new class of antibiotics capable of bypassing the defenses of drug-resistant bacteria, which otherwise make it difficult to cure chronic infections.Antibiotics work by disrupting cellular processes and structures – stopping bacteria from making proteins, rupturing cell walls, even damaging their DNA. Chronic infections are notoriously hard to cu...
To access content, please login or purchase a subscription.